Accueil>>Peptides>>Nucleoprotein (396-404) (TFA)

Nucleoprotein (396-404) (TFA) (Synonyms: NP 396 TFA)

Catalog No.GC39594

La nucléoprotéine (396-404) TFA est le fragment 396 À 404 du virus de la chorioméningite lymphocytaire (LCMV).

Products are for research use only. Not for human use. We do not sell to patients.

Nucleoprotein (396-404) (TFA) Chemical Structure

Taille Prix Stock Qté
1mg
102,00 $US
En stock
5mg
324,00 $US
En stock
10mg
454,00 $US
En stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Avis des clients

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Nucleoprotein (396-404) TFA is the 396 to 404 fragment of lymphocytic choriomeningitis virus (LCMV). Nucleoprotein (396-404) TFA is the H-2D(b)-restricted immunodominant epitope and can be used as a molecular model of viral antigen [1][2].

[1]. Gairin JE, et al. Optimal lymphocytic choriomeningitis virus sequences restricted by H-2Db major histocompatibility complex class I molecules and presented to cytotoxic T lymphocytes. J Virol. 1995 Apr;69(4):2297-305. [2]. Hudrisier D, et al. Structural and functional identification of major histocompatibility complex class I-restricted self-peptides as naturally occurring molecular mimics of viral antigens. Possible role in CD8+ T cell-mediated, virus-induced autoimmune disease. J Biol Chem. 2001 Jun 1;276(22):19396-403. Epub 2001 Mar 8.

Avis

Review for Nucleoprotein (396-404) (TFA)

Average Rating: 5 ★★★★★ (Based on Reviews and 30 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Nucleoprotein (396-404) (TFA)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.